-
公开(公告)号:US11525831B2
公开(公告)日:2022-12-13
申请号:US16743906
申请日:2020-01-15
Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY , THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Inventor: Joshua LaBaer , Jie Wang , Ji Qui , Garrick Wallstrom , Karen Anderson , Jin Park , Jonine Figueroa
IPC: G01N33/564 , G01N33/574 , C07K16/30 , C12Q1/6886 , C12N15/11
Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).
-
公开(公告)号:US20170363631A1
公开(公告)日:2017-12-21
申请号:US15534203
申请日:2015-12-09
Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY , NATIONAL INSTITUTES OF HEALTH
Inventor: Joshua LaBaer , Jie Wang , Ji Qiu , Garrick Wallstrom , Karen Anderson , Jin Park , Jonine Figueroa
IPC: G01N33/574 , C12Q1/68 , C07K16/30 , C12N15/11
CPC classification number: G01N33/57415 , C07K16/3015 , C12N15/11 , C12Q1/6886 , C12Q2600/112 , C12Q2600/118 , C12Q2600/158 , G01N33/564
Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).
-
公开(公告)号:US20240402178A1
公开(公告)日:2024-12-05
申请号:US18804843
申请日:2024-08-14
Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY , THE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Inventor: Joshua LaBaer , Jie Wang , Ji Qiu , Garrick Wallstrom , Karen Anderson , Jin Park , Jonine Figueroa
IPC: G01N33/574 , C07K16/30 , C12N15/11 , C12Q1/6886 , G01N33/564
Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).
-
公开(公告)号:US20200010899A1
公开(公告)日:2020-01-09
申请号:US16532138
申请日:2019-08-05
Inventor: Joshua LaBaer , Kristin Gillis , Garrick Wallstrom , Jin Park , Vel Murugan , Mitch Magee
IPC: C12Q1/6883
Abstract: Disclosed herein are compositions and methods for accurately estimating the absorbed dose of radiation indicated by a subject based on the expression pattern of a panel of radiation-modulated (RM) genes at various time points following exposure of the subject to ionizing radiation.
-
公开(公告)号:US12085569B2
公开(公告)日:2024-09-10
申请号:US17940883
申请日:2022-09-08
Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY , THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Inventor: Joshua LaBaer , Jie Wang , Ji Qiu , Garrick Wallstrom , Karen Anderson , Jin Park , Jonine Figueroa
IPC: G01N33/574 , C07K16/30 , C12Q1/6886 , G01N33/564 , C12N15/11
CPC classification number: G01N33/57415 , C07K16/3015 , C12Q1/6886 , G01N33/564 , C12N15/11 , C12Q2600/112 , C12Q2600/118 , C12Q2600/158
Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).
-
公开(公告)号:US10787710B2
公开(公告)日:2020-09-29
申请号:US16532138
申请日:2019-08-05
Inventor: Joshua LaBaer , Kristin Gillis , Garrick Wallstrom , Jin Park , Vel Murugan , Mitch Magee
IPC: C12Q1/6883 , C12Q1/6827
Abstract: Disclosed herein are compositions and methods for accurately estimating the absorbed dose of radiation indicated by a subject based on the expression pattern of a panel of radiation-modulated (RM) genes at various time points following exposure of the subject to ionizing radiation.
-
公开(公告)号:US20250019765A1
公开(公告)日:2025-01-16
申请号:US18896122
申请日:2024-09-25
Inventor: Joshua LaBaer , Kristin Gillis , Garrick Wallstrom , Jin Park , Vel Murugan , Mitch Magee
IPC: C12Q1/6883 , C12Q1/6827
Abstract: Disclosed herein are compositions and methods for accurately estimating the absorbed dose of radiation indicated by a subject based on the expression pattern of a panel of radiation-modulated (RM) genes at various time points following exposure of the subject to ionizing radiation.
-
公开(公告)号:US20230079737A1
公开(公告)日:2023-03-16
申请号:US17940883
申请日:2022-09-08
Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY , THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Inventor: Joshua LaBaer , Jie Wang , Ji Qiu , Garrick Wallstrom , Karen Anderson , Jin Park , Jonine Figueroa
IPC: G01N33/574 , G01N33/564 , C07K16/30 , C12Q1/6886
Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).
-
公开(公告)号:US20200182874A1
公开(公告)日:2020-06-11
申请号:US16743906
申请日:2020-01-15
Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY , NATIONAL CANCER INSTITUTE
Inventor: Joshua LaBaer , Jie Wang , Ji Qui , Garrick Wallstrom , Karen Anderson , Jin Park , Jonine Figueroa
IPC: G01N33/574 , C12Q1/6886 , C07K16/30 , G01N33/564
Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).
-
公开(公告)号:US20190004051A1
公开(公告)日:2019-01-03
申请号:US16069111
申请日:2017-01-11
Inventor: Joshua Labaer , Ji Qiu , Jie Wang , Garrick Wallstrom , Jin Park , William Rom , Harvey Pass
IPC: G01N33/574
Abstract: An immune-proteomic screening of AAb responses using protein arrays has identified two panels of Aab (antigen/antibody complexes) that can potentially differentiate lung adenocarcinoma from smoker controls as well as CT positive benign lung disease. The resulting biomarkers appear to have high specificity so that high risk subjects with a positive CT screen and a positive serum test should get more invasive test such as needle biopsy for a timely cancer diagnosis, among other advantages.
-
-
-
-
-
-
-
-
-